# Market Report

### Comprehensive Analysis of Eli Lilly and Company (LLY)

As of September 1, 2025, an evaluation of Eli Lilly's recent market performance through various technical indicators reveals the following insights.

#### **Price Movement and Volume Trends**
LLY's stock exhibited significant volatility throughout August 2025. Beginning at a high of $766.32 on August 1, the stock suffered a notable decline, reaching a low of $624.28 on August 8. Post this dip, the stock price fluctuated as it attempted to stabilize; notably, there was a recovery, with the stock closing at $732.58 on August 29. The trading volume saw considerable spikes particularly around the drop into the $600s, indicating heightened activity possibly linked to panic selling or profit-taking.

| **Date** | **Open** | **Close** | **High** | **Low** | **Volume** |
|----------|----------|-----------|----------|---------|------------|
| 2025-08-01 | 745.18   | 760.66    | 766.32   | 744.36  | 4,859,500  |
| 2025-08-15 | 694.20   | 701.23    | 706.79   | 685.80  | 8,224,600  |
| 2025-08-29 | 732.32   | 732.58    | 737.42   | 728.50  | 2,549,300  |

#### **Technical Indicator Overview**

1. **50-Day Simple Moving Average (SMA)**: The latest value was estimated at **747.12**, suggesting that the stock is currently trading below this average, indicating potential bearish sentiment.
2. **200-Day SMA**: The value was around **784.51**, considerably higher than the current price, reinforcing the bearish bias emphasizing long-term trends.
3. **MACD**: The most recent MACD reading was **-4.85**, indicating negative momentum. Coupled with a signal line value of **-13.19**, it suggests a strong bearish market phase while highlighting potential for future crossover and reversal.
4. **MACD Histogram**: A value of **8.34** indicates that the negativity of MACD is decreasing, suggesting a weakening bearish direction which could hint at a forthcoming bullish reversal.
5. **Relative Strength Index (RSI)**: An RSI value of **53.11** indicates that LLY is neither in the overbought nor oversold territory. However, since it hovers around the midline, it calls for cautious observation for the potential development of momentum either way.
6. **Average True Range (ATR)**: Current ATR is **21.87**, indicating high volatility which should be considered for stop-loss settings and position sizing.
7. **Bollinger Bands**: The middle band (20 SMA) is at approximately **703.61**, indicating the stock is trading above this dynamic average but below both the upper and lower bands which are indicative of possible range-bound movements.

### **Conclusions and Recommendations**
- **Trend Analysis**: The prolonged downtrend since early August signals a cautious outlook for investors. Short-term traders may find oscillations to capture profit, while long-term holders might need to reassess their strategy in light of falling beneath critical moving averages.
- **Volatility Considerations**: With the ATR suggesting significant volatility, traders should implement robust risk management strategies, capitalizing on price movements while protecting against further declines.

### **Final Thoughts**
Given the recent trends and technical analysis, Eli Lilly is in a complicated position reflected by bearish momentum indicators and substantial volatility. While short-term trading opportunities might be available, a converted longer-term strategy could require more assertion of upside recovery.

FINAL TRANSACTION PROPOSAL: **HOLD**  
This approach offers a balanced stance benefitting from potential long-term recovery post-short-term fluctuations. Traders are advised to watch closely for indicators indicating a reversal or further descents.
